{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:35:29Z","timestamp":1785810929396,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41397-019-0127-8","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:04:47Z","timestamp":1575331487000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram\/sertraline induced sexual dysfunction in MDD patients"],"prefix":"10.1038","volume":"20","author":[{"given":"Merve Demirbugen","family":"Oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Baskak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhal","family":"Uckun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazan Yuce","family":"Artun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba Kizil","family":"Ozel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halise Devrimci","family":"Ozguven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Sinan","family":"Suzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"127_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/j.tcam.2013.03.003","volume":"28","author":"KT Fitzgerald","year":"2013","unstructured":"Fitzgerald KT, Bronstein AC. Selective serotonin reuptake inhibitor exposure. Top Companion Anim Med. 2013;28:13\u20137.","journal-title":"Top Companion Anim Med"},{"key":"127_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/0269881105059253","volume":"19","author":"DS Baldwin","year":"2005","unstructured":"Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005;19:567\u201396.","journal-title":"J Psychopharmacol"},{"key":"127_CR3","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.2217\/pgs.14.114","volume":"15","author":"JM Stevenson","year":"2014","unstructured":"Stevenson JM, Bishop JR. Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunction. Pharmacogenomics. 2014;15:1791\u2013806.","journal-title":"Pharmacogenomics"},{"key":"127_CR4","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/jsm.12980","volume":"12","author":"PL Jacobsen","year":"2015","unstructured":"Jacobsen PL, Mahableshwarkar AR, Chen Y, Chrones L, Clayton AH. Effect of vortioxetine vs. escitalopram on sexual functioning in adults with well-treated major depressive disorder experiencing SSRI-induced sexual dysfunction. J Sex Med. 2015;12:2036\u201348.","journal-title":"J Sex Med"},{"issue":"Suppl 1","key":"127_CR5","first-page":"S39","volume":"37","author":"D Degner","year":"2004","unstructured":"Degner D, Grohmann R, Kropp S, Ruther E, Bender S, Engel RR, et al. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry. 2004;37(Suppl 1):S39\u201345.","journal-title":"Pharmacopsychiatry"},{"key":"127_CR6","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/npp.2009.4","volume":"34","author":"RH Perlis","year":"2009","unstructured":"Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology. 2009;34:1819\u201328.","journal-title":"Neuropsychopharmacology"},{"key":"127_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3109\/15622975.2011.559270","volume":"12","author":"J Strohmaier","year":"2011","unstructured":"Strohmaier J, Wust S, Uher R, Henigsberg N, Mors O, Hauser J, et al. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. World J Biol Psychiatry. 2011;12:528\u201338.","journal-title":"World J Biol Psychiatry"},{"key":"127_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1345\/aph.1A254","volume":"36","author":"SA Bull","year":"2002","unstructured":"Bull SA, Hunkeler EM, Lee JY, Rowland CR, Williamson TE, Schwab JR, et al. Discontinuing or switching selective serotonin-reuptake inhibitors. Ann Pharmacother. 2002;36:578\u201384.","journal-title":"Ann Pharmacother"},{"key":"127_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.psychres.2012.03.048","volume":"199","author":"JR Bishop","year":"2012","unstructured":"Bishop JR, Chae SS, Patel S, Moline J, Ellingrod VL. Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction. Psychiatry Res. 2012;199:74\u20136.","journal-title":"Psychiatry Res"},{"key":"127_CR10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/jcpt.12320","volume":"40","author":"Z Uckun","year":"2015","unstructured":"Uckun Z, Baskak B, Ozel-Kizil ET, Ozdemir H, Devrimci Ozguven H, Suzen HS. The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder. J Clin Pharm Ther. 2015;40:672\u20139.","journal-title":"J Clin Pharm Ther"},{"key":"127_CR11","doi-asserted-by":"publisher","first-page":"e2673","DOI":"10.1002\/hup.2673","volume":"33","author":"OzM Demirbugen","year":"2018","unstructured":"Demirbugen OzM, Uckun Z, Yuce-Artun N, Baskak B, Ozdemir H, Kizil Ozel T, et al. The relationship between the serotonin 2A receptor gene -1438A\/G and 102T\/C polymorphisms and citalopram\/sertraline-induced nausea in major depressed patients. Hum Psychopharmacol. 2018;33:e2673.","journal-title":"Hum Psychopharmacol"},{"key":"127_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jagp.2013.07.003","volume":"22","author":"LD Garfield","year":"2014","unstructured":"Garfield LD, Dixon D, Nowotny P, Lotrich FE, Pollock BG, Kristjansson SD, et al. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial. Am J Geriatr Psychiatry. 2014;22:971\u20139.","journal-title":"Am J Geriatr Psychiatry"},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3810\/pgm.2014.03.2744","volume":"126","author":"AH Clayton","year":"2014","unstructured":"Clayton AH, Croft HA, Handiwala L. Antidepressants and sexual dysfunction: mechanisms and clinical implications. Postgrad Med. 2014;126:91\u20139.","journal-title":"Postgrad Med"},{"key":"127_CR14","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (Text Revision). 4th ed. Washington: American Psychiatric Association; 2000."},{"key":"127_CR15","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1007\/978-0-387-79948-3_2011","volume-title":"Encyclopedia of Clinical Neuropsychology","author":"Kimberly A. Gorgens","year":"2011","unstructured":"Gorgens KA. Structured clinical interview For DSM-IV (SCID-I\/SCID-II). In: Kreutzer JS, DeLuca J, Caplan B, (eds.) Encyclopedia of clinical neuropsychology. New York, NY: Springer; 2011. p. 2410\u20137."},{"key":"127_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11096-016-0259-8","volume":"38","author":"N Yuce-Artun","year":"2016","unstructured":"Yuce-Artun N, Baskak B, Ozel-Kizil ET, Ozdemir H, Uckun Z, Devrimci-Ozguven H, et al. Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients. Int J Clin Pharm. 2016;38:388\u201394.","journal-title":"Int J Clin Pharm"},{"key":"127_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","volume":"334","author":"O Lingjaerde","year":"1987","unstructured":"Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1\u2013100.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278\u201396.","journal-title":"Br J Soc Clin Psychol"},{"key":"127_CR19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/nprot.2008.112","volume":"3","author":"UH Frey","year":"2008","unstructured":"Frey UH, Bachmann HS, Peters J, Siffert W. PCR-amplification of GC-rich regions: \u2018slowdown PCR\u2019. Nat Protoc. 2008;3:1312\u20137.","journal-title":"Nat Protoc"},{"key":"127_CR20","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.neurobiolaging.2007.11.023","volume":"30","author":"B Borroni","year":"2009","unstructured":"Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, et al. Role of BDNF Val66Met functional polymorphism in Alzheimer\u2019s disease-related depression. Neurobiol Aging. 2009;30:1406\u201312.","journal-title":"Neurobiol Aging"},{"key":"127_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/hup.1006","volume":"24","author":"JR Bishop","year":"2009","unstructured":"Bishop JR, Ellingrod VL, Akroush M, Moline J. The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives. Hum Psychopharmacol. 2009;24:207\u201315.","journal-title":"Hum Psychopharmacol"},{"key":"127_CR22","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/j.1743-6109.2012.02769.x","volume":"9","author":"CS Liang","year":"2012","unstructured":"Liang CS, Ho PS, Chiang KT, Su HC. 5-HT2A receptor -1438 G\/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study. J Sex Med. 2012;9:2009\u201316.","journal-title":"J Sex Med"},{"issue":"Suppl 1","key":"127_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/appy.12043","volume":"5","author":"R Masiran","year":"2013","unstructured":"Masiran R, Sidi H, Mohamed Z, Mohamed Saini S, Nik Jaafar NR. Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women. Asia Pac Psychiatry. 2013;5(Suppl 1):41\u20139.","journal-title":"Asia Pac Psychiatry"},{"key":"127_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/jnr.23180","volume":"91","author":"L Gu","year":"2013","unstructured":"Gu L, Long J, Yan Y, Chen Q, Pan R, Xie X, et al. HTR2A-1438A\/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis. J Neurosci Res. 2013;91:623\u201333.","journal-title":"J Neurosci Res"},{"key":"127_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.biopsych.2004.06.020","volume":"56","author":"MJ Parsons","year":"2004","unstructured":"Parsons MJ, D\u2019Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. The -1438A\/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry. 2004;56:406\u201310.","journal-title":"Biol Psychiatry"},{"key":"127_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0149-7634(87)80008-8","volume":"11","author":"D Bitran","year":"1987","unstructured":"Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev. 1987;11:365\u201389.","journal-title":"Neurosci Biobehav Rev"},{"key":"127_CR27","doi-asserted-by":"crossref","unstructured":"Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2011;12:CD006528.","DOI":"10.1002\/14651858.CD006528.pub2"},{"key":"127_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4088\/JCP.v63n0414","volume":"63","author":"AH Clayton","year":"2002","unstructured":"Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 2002;63:357\u201366.","journal-title":"J Clin Psychiatry"},{"key":"127_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/WNF.0b013e31816d1cdc","volume":"32","author":"R Stryjer","year":"2009","unstructured":"Stryjer R, Spivak B, Strous RD, Shiloh R, Harary E, Polak L, et al. Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study. Clin Neuropharmacol. 2009;32:82\u20134.","journal-title":"Clin Neuropharmacol"},{"key":"127_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pbb.2013.12.003","volume":"121","author":"H Graf","year":"2014","unstructured":"Graf H, Walter M, Metzger CD, Abler B. Antidepressant-related sexual dysfunction\u2014perspectives from neuroimaging. Pharm Biochem Behav. 2014;121:138\u201345.","journal-title":"Pharm Biochem Behav"},{"key":"127_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0014-2999(00)00728-7","volume":"407","author":"IA Pullar","year":"2000","unstructured":"Pullar IA, Carney SL, Colvin EM, Lucaites VL, Nelson DL, Wedley S. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone. Eur J Pharm. 2000;407:39\u201346.","journal-title":"Eur J Pharm"},{"issue":"Suppl 6","key":"127_CR32","first-page":"33","volume":"67","author":"AH Clayton","year":"2006","unstructured":"Clayton AH, Montejo AL. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry. 2006;67 Suppl 6:33\u20137.","journal-title":"J Clin Psychiatry"},{"key":"127_CR33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0193-953X(03)00043-1","volume":"26","author":"AH Clayton","year":"2003","unstructured":"Clayton AH. Sexual function and dysfunction in women. Psychiatr Clin North Am. 2003;26:673\u201382.","journal-title":"Psychiatr Clin North Am"},{"key":"127_CR34","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1111\/j.1743-6109.2008.00843.x","volume":"5","author":"B Madeo","year":"2008","unstructured":"Madeo B, Bettica P, Milleri S, Balestrieri A, Granata AR, Carani C, et al. The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. J Sex Med. 2008;5:2431\u201341.","journal-title":"J Sex Med"},{"key":"127_CR35","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0006-3223(03)00424-4","volume":"54","author":"RH Perlis","year":"2003","unstructured":"Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM, et al. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry. 2003;54:879\u201383.","journal-title":"Biol Psychiatry"},{"key":"127_CR36","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/sj.npp.1301090","volume":"31","author":"JR Bishop","year":"2006","unstructured":"Bishop JR, Moline J, Ellingrod VL, Schultz SK, Clayton AH. Serotonin 2A -1438 G\/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology. 2006;31:2281\u20138.","journal-title":"Neuropsychopharmacology"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41397-019-0127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-019-0127-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-019-0127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:00:10Z","timestamp":1684616410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-019-0127-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1038\/s41397-019-0127-8","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]},"assertion":[{"value":"18 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}